Exxon Mobil Corporation (NEO:XOM)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	644,973	680,255	527,720	614,788	327,828	222,078
Market Cap Growth	1.99%	28.90%	-14.16%	87.53%	47.62%	-42.01%
Enterprise Value	689,139	713,970	549,034	644,515	402,180	307,677
Last Close Price	20.17	20.13	22.03	-	-	-
PE Ratio	15.25	14.04	11.10	8.15	11.24	-
PS Ratio	1.44	1.39	1.19	1.13	0.94	0.97
PB Ratio	1.75	1.75	1.88	2.24	1.48	1.06
P/TBV Ratio	1.80	1.79	1.95	2.33	1.54	1.11
P/FCF Ratio	-	15.39	11.95	7.78	7.19	-
P/OCF Ratio	-	8.59	7.22	5.92	5.38	11.88
EV/Sales Ratio	1.52	1.46	1.24	1.19	1.15	1.34
EV/EBITDA Ratio	6.92	7.72	6.27	5.31	7.18	14.19
EV/EBIT Ratio	11.41	11.97	8.48	6.78	12.77	-
EV/FCF Ratio	17.35	16.16	12.43	8.16	8.82	-
Debt / Equity Ratio	0.14	0.18	0.22	0.23	0.30	0.44
Debt / EBITDA Ratio	0.58	0.70	0.68	0.51	1.12	3.61
Debt / FCF Ratio	1.34	1.57	1.43	0.80	1.47	-
Asset Turnover	0.73	0.82	0.90	1.13	0.83	0.52
Inventory Turnover	9.12	9.70	9.17	12.43	10.04	6.56
Quick Ratio	0.82	0.95	1.07	1.03	0.69	0.44
Current Ratio	1.25	1.31	1.48	1.41	1.04	0.80
Return on Equity (ROE)	11.83%	14.52%	18.00%	30.45%	13.89%	-12.81%
Return on Assets (ROA)	5.28%	6.25%	8.22%	12.40%	4.63%	-0.72%
Return on Capital (ROIC)	7.63%	8.95%	12.02%	18.36%	6.68%	-1.02%
Return on Capital Employed (ROCE)	10.10%	10.80%	15.80%	23.40%	8.80%	-
Earnings Yield	6.56%	7.12%	9.01%	12.27%	8.89%	-12.88%
FCF Yield	6.16%	6.50%	8.37%	12.85%	13.92%	-1.50%
Dividend Yield	-	27.45%	22.06%	-	-	-
Payout Ratio	-	49.60%	41.49%	26.80%	64.77%	-
Buyback Yield / Dilution	-9.08%	-6.07%	3.64%	1.64%	-0.09%	-0.02%
Total Shareholder Return	-	21.38%	25.70%	1.64%	-0.09%	-0.02%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.